THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL

• Main Authors: Y. R. Kasherininov (Author), E. K. Shavarova (Author), A. A. Shavarov (Author), N. V. Vachrameeva (Author), A. N. Krutikov (Author), E. V. Smirnova (Author), A. O. Коnrady (Author), E. V. Shlyakhto (Author)
• Format: Book
• Published: Столичная издательская компания, 2016-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim. To evaluate effects of long-term treatment with rilmenidine compared with atenolol on lipid and glucose metabolism and cardiovascular remodeling in hypertension. Material and methods. 37 patients with hypertension were randomized to rilmenidine 1-2 mg/day or atenolol 50-100 mg/day for 26 weeks....